Ozempic has made headlines as a go-to medication for managing diabetes and aiding weight loss, but its popularity comes with some surprising side effects. While many celebrate its effectiveness, reports of unexpected issues like vision changes have raised concerns among users.
It’s a reminder that even the most promising treatments can have hidden risks, and understanding how they affect your body is essential. As more people turn to Ozempic for its benefits, staying informed about its potential impact on your health is more important than ever.
The American Academy of Ophthalmology states that semaglutide, a diabetes drug has gained attention for its potential benefits in blood sugar control and obesity treatment. It is tested that its medications include Ozempic, Wegovy, and Rybelsus.
The above source reports that Ozempic studies show semaglutide can help people control their blood sugar but can also cause vision changes, including blurred vision, worsening of diabetic retinopathy, and macular complications. Furthermore, it is mentioned that older patients are more likely to experience blurred vision when starting semaglutide, as the eye’s lens becomes less flexible as we age.
”One new study suggests there may be a connection between semaglutide use and increased risk for a blinding eye disease called non-arteritic anterior ischemic optic neuropathy (NAION). However, experts say there isn’t enough data yet to suggest patients should be concerned or should stop taking their medications. People who have diabetes are already at risk for NAION, whether they use semaglutide or not. ”
According to All About Vision, Ozempic can have eye and systemic side effects, including diabetic retinopathy, gastrointestinal issues, dehydration, fatigue, hair loss, sleep disruptions, and other issues. It is further stated that people with diabetes are at risk for conditions such as cataracts, glaucoma, and dry eye. Studies are said to be ongoing to determine the effects of semaglutide on people with retinal issues caused by diabetes.
